Palo Alto, CA
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
maplightrx.comThese are collections MapLight Therapeutics is a part of. Click on the collection name to view similar companies.
Series D
$372,500,000
Series C
$225,000,000
Series Unknown
$29,999,999
Grant
$8,100,000
Series Unknown
$5,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on MapLight Therapeutics.